Safety and Immunogenicity Study of the Hepatitis B Virus (HBV) Vaccine, HEPLISAV Compared to Engerix-B Vaccine
Clinical trial NCT01005407 · COMPLETED
Trial details
- NCT number
- NCT01005407
- Sponsor
- Dynavax Technologies Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2011-01-01
- Enrollment
- 2452
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.